Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persantine Response Variation in CAD
NCT00763009Phase 4Terminated
- Sponsor
- UConn Health
- Start
- Sep 2002
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dipyridamole in coronary artery disease (CAD), sponsored by UConn Health. Started Sep 2002; status: terminated.
02
Drugs
dipyridamole
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00763009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00763009.